Clinical Trial Update: A Study of Xevinapant With Cisplatin and Radiation Therapy After Surgery in People With Head and Neck Cancer [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial is evaluating Xevinapant in combination with cisplatin and radiation therapy after surgery for head and neck cancer; the study is curre…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Head and Neck Cancer

Drugs mentioned

• CISPLATIN (cisplatin)
• Xevinapant (Xevinapant)

Snippet

Sponsor: Memorial Sloan Kettering Cancer Center | Conditions: Head and Neck Cancer | Phase 2 | Status: ACTIVE_NOT_RECRUITING